Biomarkers in lung cancer
Department of Medical Oncology, CRO-IRCCS, National Cancer Institute, Aviano, PN, Italy. email@example.com
01 June 2010
Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.
Share and Cite
Alessandra Bearz, Massimiliano Berretta, Alessandro Cappellani, Arben Lleshi, Eleonora Berto, Lucia Fratino, Umberto Tirelli. Biomarkers in lung cancer. Frontiers in Bioscience-Elite. 2010. 2(3); 1099-1104.